IDEXX Laboratories, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | $2.71 | $2.72 | $2.71 |
Q2 2024 | 2 | $2.88 | $2.88 | $2.88 |
Q3 2024 | 2 | $2.67 | $2.69 | $2.68 |
Q4 2024 | 7 | $2.31 | $2.46 | $2.40 |
Q1 2025 | 5 | $2.96 | $3.03 | $3.00 |
Q2 2025 | 4 | $3.18 | $3.23 | $3.21 |
Q3 2025 | 4 | $3.03 | $3.08 | $3.06 |
Q4 2025 | 4 | $2.74 | $2.78 | $2.76 |
Q1 2026 | 3 | $3.41 | $3.46 | $3.44 |
Q2 2026 | 3 | $3.62 | $3.68 | $3.65 |
Q3 2026 | 3 | $3.56 | $3.61 | $3.58 |
Q4 2026 | 3 | $3.30 | $3.35 | $3.33 |
IDEXX Laboratories, Inc. Earnings Date And Information
IDEXX Laboratories, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $2.8 earnings per share for the quarter, topping analysts' consensus estimates of $2.68 by $0.12. The company had revenue of 975.54 M for the quarter and had revenue of 3.66 B for the year. IDEXX Laboratories, Inc. has generated $10 earnings per share over the last year ($10.06 diluted earnings per share) and currently has a price-to-earnings ratio of 41.3. IDEXX Laboratories, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, February 2nd, 2025 based on prior year's report dates.
IDEXX Laboratories, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/31/2024 | Q3 2024 | $2.68 | $2.82 | 0.14 | $980.32 M | $975.54 M |
08/06/2024 | Q2 2024 | $2.88 | $2.46 | -0.42 | $1.01 B | $1.00 B |
05/01/2024 | Q1 2024 | $2.67 | $2.84 | 0.17 | $964.10 M | |
02/22/2024 | Q4 2023 | $2.34 | $901.60 M | |||
11/01/2023 | Q3 2023 | $2.37 | $2.55 | 0.18 | $926.88 M | $915.53 M |
08/01/2023 | Q2 2023 | $2.47 | $2.70 | 0.23 | $934.59 M | $943.63 M |
05/02/2023 | Q1 2023 | $2.42 | $2.58 | 0.16 | $900.20 M | |
02/16/2023 | Q4 2022 | $2.08 | $828.57 M | |||
11/01/2022 | Q3 2022 | $2.04 | $2.17 | 0.13 | $830.00 M | $841.66 M |
08/02/2022 | Q2 2022 | $1.56 | $1.57 | 0.01 | $863.14 M | $860.55 M |
05/04/2022 | Q1 2022 | $2.26 | $2.30 | 0.04 | $836.55 M | |
02/16/2022 | Q4 2021 | $1.92 | $801.09 M | |||
11/02/2021 | Q3 2021 | $1.91 | $2.06 | 0.15 | $797.61 M | $810.42 M |
07/30/2021 | Q2 2021 | $2.02 | $2.37 | 0.35 | $788.86 M | $826.14 M |
05/04/2021 | Q1 2021 | $1.72 | $2.39 | 0.67 | $777.71 M | |
02/12/2021 | Q4 2020 | $2.04 | $720.94 M | |||
10/29/2020 | Q3 2020 | $1.43 | $1.71 | 0.28 | $672.48 M | $721.79 M |
07/31/2020 | Q2 2020 | $1.17 | $1.75 | 0.58 | $593.05 M | $637.59 M |
04/30/2020 | Q1 2020 | $1.20 | $1.31 | 0.11 | $626.34 M | |
02/14/2020 | Q4 2019 | $1.05 | $605.45 M |
IDEXX Laboratories, Inc. Earnings: Frequently Asked Questions
-
When is IDEXX Laboratories, Inc.'s earnings date?
IDEXX Laboratories, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, February 2nd, 2025 based off last year's report dates.
-
Did IDEXX Laboratories, Inc. beat their earnings estimates last quarter?
In the previous quarter, IDEXX Laboratories, Inc. (:IDXX) reported $2.8 earnings per share (EPS) to beat the analysts' consensus estimate of $2.68 by $0.12.
-
How can I listen to IDEXX Laboratories, Inc.'s earnings conference call?
The conference call for IDEXX Laboratories, Inc.'s latest earnings report can be listened to online.
-
How can I read IDEXX Laboratories, Inc.'s conference call transcript?
The conference call transcript for IDEXX Laboratories, Inc.'s latest earnings report can be read online.
-
How much revenue does IDEXX Laboratories, Inc. generate each year?
IDEXX Laboratories, Inc. (:IDXX) has a recorded annual revenue of $3.66 B.
-
How much profit does IDEXX Laboratories, Inc. generate each year?
IDEXX Laboratories, Inc. (:IDXX) has a recorded net income of $3.66 B. IDEXX Laboratories, Inc. has generated $10.17 earnings per share over the last four quarters.
-
What is IDEXX Laboratories, Inc.'s price-to-earnings ratio?
IDEXX Laboratories, Inc. (:IDXX) has a price-to-earnings ratio of 41.3 and price/earnings-to-growth ratio is 15.59.